Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 3, 2022Arthritis Care & ResearchOpen Access

Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study

View Full Paper
Ask AI
Bookmark
Share

Authors

NRNicolino RupertoDLDaniel J. LovellABAlberto Berman

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ruperto et al. (2022) studied this question.

synapsesocial.com/papers/69fffe0d6018b8d0892da368https://doi.org/10.1002/acr.24989
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register2015 · 52 citations
  2. 2Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis2006 · 83 citations
  3. 3Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials2018 · 111 citations
  4. 4Advances in the treatment of polyarticular juvenile idiopathic arthritis2015 · 37 citations
  5. 5Proxy‐reported health‐related quality of life of patients with juvenile idiopathic arthritis: The pediatric rheumatology international trials organization multinational quality of life cohort study2007 · 165 citations